Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04369612

Home Based Monitoring of Kidney Transplants Utilizing Capillary Microsamples

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Renal transplant recipients are followed as out patients at the transplant center for about 8 weeks after surgery. Between 1-2 weeks after surgery, 50 standard immunological patients will be randomized (1:1) to either follow standard of care (SOC) or having every second poli clinical visit without entering the hospital HBM; Home Based Monitoring). They are to take a capillary finger-prick blood sample themselves, send it to the laboratory for analysis and then they will get a telecom follow-up that day from their transplant physician. Outcome is no difference with regards to being able to follow the randomized follow-up procedure.

Detailed description

Renal transplant recipients are followed as out patients at the transplant center for about 8 weeks after surgery. Between 1-2 weeks after surgery, 50 standard immunological patients (i.e. first, kidney (only) transplants, no donors specific antibodies (DSA), panel reactive antibodies (PRA), ABO blood type compatible transplant) will be randomized (1:1) to either follow standard of care (SOC) or having every second poli clinical visit without entering the hospital HBM; Home Based Monitoring). They are to take a capillary finger-prick blood sample themselves and send it to the laboratory for analysis (creatinine, hemoglobin, tacrolimus and mycophenolate) and then they will get a telecom follow-up that day from their transplant physician. Outcome is no difference with regards to being able to follow the randomized follow-up procedure without having acute rejection episodes and no need for extra ou-patients visits for any reason. End of study is week 7-8 after transplantation.

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard follow-upStandard post-transplant follow-up
PROCEDUREHome-based monitoringPatients take capillary blood sample by finger-prick and send to lab for analyses. Telecom follow-up that day by treating physician

Timeline

Start date
2020-04-28
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2020-04-30
Last updated
2024-04-04

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04369612. Inclusion in this directory is not an endorsement.